Skip to content
buyModerate

Dennis Matheis bought $458k of LUCD

director at Lucid Diagnostics Inc.. 350,000 shares at an average of $1.31, traded May 20, 2025, filed May 23, 2025.

Conviction score
42
Value
$458k
350,000 shares
Holdings after
565,443
+162% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $458k at market
    +17
  • Relative to holdings
    Holdings up 162%
    +10
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001062993-25-010245, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 20, 2025POpen-market purchase
Common Stock
+187,098$1.30$242k402,541May 23, 2025
May 21, 2025POpen-market purchase
Common Stock
+129,684$1.32$172k532,225May 23, 2025
May 22, 2025POpen-market purchase
Common Stock
+33,218$1.32$44k565,443May 23, 2025

Related signals

Other insiders at Lucid Diagnostics Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
28Weak
LUCDbuy
Lucid Diagnostics Inc.
Dennis Matheis
director
$102k
100,000 shares
+18%
40Moderate
LUCDbuy
Lucid Diagnostics Inc.
Dennis Matheis
director
$458k
350,000 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dennis Matheis bought $458k of LUCD | InsiderTell